Dr. Christenson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 N. Wolfe Street
Baltimore, MD 21287Phone+1 410-955-8893Fax+1 410-367-2194- Is this information wrong?
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 2013 - 2016
Drexel University College of MedicineClass of 2013
Certifications & Licensure
FL State Medical License 2021 - Present
MD State Medical License 2016 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors Start of enrollment: 2022 Oct 06
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- The utilization of circulating tumor DNA to predict the risk and location of relapse after curative-intent local therapy in oligometastatic colorectal cancer.Madison Hidalgo, Shannon N Radomski, Sundas Ali, Kelly J Lafaro, Christopher Shubert, Haniee Chung, Eric S Christenson> ;Journal of Gastrointestinal Surgery. 2024 Apr 1
- Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer.Liu, I., Gearhart, S., Ke, S., Hu, C., Chung, H., Efron, J., Gabre-Kidan, A., Najjar, P., Atallah, C., Safar, B., Christenson, E., Azad, N., Lee, V., Zaheer, A., Birkn...> ;Surgery Open Science. 2024 Mar 1
- Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer.Gearhart, S., Alden, S., Lee, V., Narang, A., Meyer, J., Christenson, E.> ;The Oncologist. 2024 Mar 4
- Join now to see all
Press Mentions
NextCure Presents Initial Data from Clinical Trial of NC762 and a Trial in Progress Poster for NC410 Combo at the 2022 Society for Immunotherapy of Cancer Annual MeetingNovember 7th, 2022- A Mitochondria-Anchored Isoform of the Actin-Nucleating Spire Protein Regulates Mitochondrial DivisionAugust 25th, 2020
Hospital Affiliations
Johns Hopkins HospitalBaltimore, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
